CO2020004233A2 - Vesículas extracelulares bacterianas - Google Patents
Vesículas extracelulares bacterianasInfo
- Publication number
- CO2020004233A2 CO2020004233A2 CONC2020/0004233A CO2020004233A CO2020004233A2 CO 2020004233 A2 CO2020004233 A2 CO 2020004233A2 CO 2020004233 A CO2020004233 A CO 2020004233A CO 2020004233 A2 CO2020004233 A2 CO 2020004233A2
- Authority
- CO
- Colombia
- Prior art keywords
- extracellular vesicles
- bacterial extracellular
- bacterial
- vesicles
- therapeutic agents
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporcionan en el presente documento métodos y composiciones relacionados con VE útiles como agentes terapéuticos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762556015P | 2017-09-08 | 2017-09-08 | |
US201862669151P | 2018-05-09 | 2018-05-09 | |
PCT/US2018/050211 WO2019051380A1 (en) | 2017-09-08 | 2018-09-10 | BACTERIAL EXTRACELLULAR (EV) VESICLES |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2020004233A2 true CO2020004233A2 (es) | 2020-04-24 |
Family
ID=63832482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2020/0004233A CO2020004233A2 (es) | 2017-09-08 | 2020-04-06 | Vesículas extracelulares bacterianas |
Country Status (14)
Country | Link |
---|---|
US (2) | US11524037B2 (es) |
EP (1) | EP3678693A1 (es) |
JP (1) | JP7369690B2 (es) |
KR (1) | KR20200053531A (es) |
CN (1) | CN111148531A (es) |
AR (1) | AR113011A1 (es) |
AU (1) | AU2018330322A1 (es) |
BR (1) | BR112020004264A2 (es) |
CA (1) | CA3075268A1 (es) |
CO (1) | CO2020004233A2 (es) |
MA (1) | MA50086A (es) |
MX (1) | MX2020002659A (es) |
TW (1) | TWI814739B (es) |
WO (1) | WO2019051380A1 (es) |
Families Citing this family (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6774664B2 (ja) * | 2016-06-14 | 2020-10-28 | コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジーKorea Research Institute Of Bioscience And Biotechnology | 退行性脳疾患の予防又は治療効果を有するアガトバキュラム属菌株及びその用途 |
IL265109B2 (en) | 2016-09-13 | 2024-05-01 | Allergan Inc | Stabilized Clostridium toxin preparations without protein |
WO2019023039A2 (en) | 2017-07-27 | 2019-01-31 | Locus Ip Company, Llc | COMPOSITIONS FOR IMPROVING THE BIOAVAILABILITY OF PHARMACEUTICAL PRODUCTS, COMPLEMENTS AND INGREDIENTS |
JP7369690B2 (ja) | 2017-09-08 | 2023-10-26 | エヴェロ バイオサイエンシズ,インコーポレーテッド | 細菌の細胞外小胞 |
EP3749340A1 (en) * | 2018-02-06 | 2020-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and immune disorders using veillonella bacteria |
KR102122898B1 (ko) * | 2018-02-26 | 2020-06-15 | 주식회사 엠디헬스케어 | 블라우티아 속 세균 유래 나노소포 및 이의 용도 |
WO2019178494A1 (en) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and inflammation using tyzzerella nexilis |
WO2019178490A1 (en) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and inflammation using klebsiella oxytoca |
WO2019178487A2 (en) | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae |
CN112135628A (zh) | 2018-03-16 | 2020-12-25 | 硕腾服务有限责任公司 | 抗白介素31的肽疫苗 |
US20210205379A1 (en) * | 2018-05-30 | 2021-07-08 | University Of Florida Research Foundation, Incorporated | Mechanistic bacterial efector to prevent apoptosis of human beta cells |
CN108949699B (zh) * | 2018-08-03 | 2020-09-04 | 江南大学 | 一种分泌美洛昔康单克隆抗体的杂交瘤细胞株及其应用 |
AU2019351019A1 (en) * | 2018-09-27 | 2021-04-22 | Research Development Foundation | Methods and probiotic compositions for the treatment of bone disorders |
CN109207425A (zh) * | 2018-09-29 | 2019-01-15 | 中国医科大学附属口腔医院 | 牙龈卟啉单胞菌诱导巨噬细胞外泌体rna表达研究方法 |
JP7240031B2 (ja) * | 2018-12-10 | 2023-03-15 | エムディー ヘルスケア インコーポレイテッド | ワイセラ属細菌由来のナノ小胞およびその用途 |
US20220047648A1 (en) * | 2019-01-09 | 2022-02-17 | Md Healthcare Inc. | Nanovesicles derived from bacteria of genus rhodococcus, and use thereof |
WO2020145661A1 (ko) * | 2019-01-09 | 2020-07-16 | 주식회사 엠디헬스케어 | 데이노코커스 속 세균 유래 나노소포 및 이의 용도 |
CN109762762A (zh) * | 2019-01-11 | 2019-05-17 | 江苏大学 | 一种脂肽的高产菌株及其制备方法和用途 |
KR102285335B1 (ko) * | 2019-02-14 | 2021-08-04 | 주식회사 엠디헬스케어 | 로치아 속 세균 유래 나노소포 및 이의 용도 |
AR118171A1 (es) * | 2019-02-22 | 2021-09-22 | Evelo Biosciences Inc | Preparaciones de membrana bacteriana |
CN110195028B (zh) * | 2019-03-08 | 2022-03-01 | 大连理工大学 | 一种堆肥低温复合发酵菌剂的制备方法及应用 |
WO2020214961A1 (en) * | 2019-04-17 | 2020-10-22 | Codiak Biosciences, Inc. | Methods of treating tuberculosis |
CN111991427A (zh) * | 2019-05-07 | 2020-11-27 | 瑞微(深圳)生物科技有限公司 | 肠道细菌在制备用于促进TCR γδ+T细胞增殖的药物中的应用 |
CN110317744B (zh) * | 2019-05-08 | 2021-11-05 | 安徽农业大学 | 一种生产蓝紫色素的马赛菌及其生产蓝紫色素的方法 |
CN114096262A (zh) * | 2019-06-11 | 2022-02-25 | 伊夫罗生物科学公司 | 分泌的微生物胞外囊泡 |
AU2020298217A1 (en) | 2019-06-20 | 2022-01-27 | Locus Ip Company, Llc | Co-cultivation of a myxobacterium and acinetobacter for enhanced production of emulsan |
MX2022000756A (es) * | 2019-07-19 | 2022-03-11 | Finch Therapeutics Holdings Llc | Metodos y productos para el tratamiento de trastornos gastrointestinales. |
US20220339208A1 (en) * | 2019-08-05 | 2022-10-27 | Evelo Biosciences, Inc. | Compositions and methods of treating psoriasis and atopic dermatitis using prevotella histicola |
CN110577910B (zh) * | 2019-09-17 | 2022-02-01 | 南京农业大学 | 一种侧孢短芽孢杆菌、抗菌脂肽及其在农业与食品上的应用 |
US11883447B2 (en) | 2019-09-18 | 2024-01-30 | Research Development Foundation | Methods and probiotic compositions for the treatment of metabolic diseases and disorders |
CN110628862A (zh) * | 2019-09-24 | 2019-12-31 | 哈尔滨工业大学 | 一种废水梯级能源回收的自聚集颗粒污泥构建方法 |
CN110982729A (zh) * | 2019-10-23 | 2020-04-10 | 江苏省中国科学院植物研究所 | 一种降解木材加工副产物杨树皮纤维素的复合菌剂 |
CN110804621A (zh) * | 2019-10-31 | 2020-02-18 | 郑州大学 | 一种内源性高表达miRNA的大肠杆菌胞外囊泡的制备方法 |
US20230081756A1 (en) * | 2019-12-31 | 2023-03-16 | Xbiome Inc. | Compositions comprising bacterial species and methods related thereto |
WO2021137494A1 (ko) * | 2020-01-02 | 2021-07-08 | 삼육대학교산학협력단 | 부티리시모나스 속 균주를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 조성물 |
WO2021142279A1 (en) * | 2020-01-10 | 2021-07-15 | Evelo Biosciences, Inc. | Compositions and methods of treatment using veillonella parvula |
WO2021146523A1 (en) * | 2020-01-17 | 2021-07-22 | Evelo Biosciences, Inc. | Solid dosage forms with improved disintegration profiles |
US20240009256A1 (en) * | 2020-02-04 | 2024-01-11 | University Of Louisville Research Foundation, Inc. | Use of probiotic bacterium-derived extracellular micro- and/or nanoparticles for the treatment of disease |
CN111052997B (zh) * | 2020-02-25 | 2022-07-01 | 青岛农业大学 | 一种提高草莓连作障碍抗性生物刺激素的制备及应用方法 |
US11744866B2 (en) | 2020-03-18 | 2023-09-05 | Sabine Hazan | Methods of preventing and treating COVID-19 infection with probiotics |
US11253534B2 (en) | 2020-03-23 | 2022-02-22 | Sabine Hazan | Method of preventing COVID-19 infection |
US11278520B2 (en) | 2020-03-31 | 2022-03-22 | Sabine Hazan | Method of preventing COVID-19 infection |
JP2023542447A (ja) * | 2020-04-03 | 2023-10-10 | デュポン ニュートリション バイオサイエンシス エーピーエス | 代謝の健康を改善するための細菌株を含む組成物 |
WO2021205444A1 (en) * | 2020-04-06 | 2021-10-14 | Yeda Research And Development Co. Ltd. | Methods of diagnosing cancer and predicting responsiveness to therapy |
KR102273234B1 (ko) * | 2020-05-08 | 2021-07-06 | 코스맥스 주식회사 | 코쿠리아 바리안스 균주 및 그의 피부 상태 개선 용도 |
KR102273232B1 (ko) * | 2020-05-08 | 2021-07-06 | 코스맥스 주식회사 | 마이크로코커스 리래 균주 및 그의 피부 상태 개선 용도 |
CN111560330B (zh) * | 2020-05-12 | 2022-04-26 | 天津科技大学 | 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用 |
GB202007452D0 (en) | 2020-05-19 | 2020-07-01 | Microbiotica Ltd | Threrapeutic bacterial composition |
WO2021242056A1 (ko) * | 2020-05-28 | 2021-12-02 | 주식회사 바이오뱅크힐링 | 비피도박테리움 속 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
TW202214275A (zh) * | 2020-06-11 | 2022-04-16 | 美商艾弗洛生物科技股份有限公司 | 使用fournierella massiliensis治療疾病和障礙之組成物及方法 |
TW202216178A (zh) * | 2020-06-11 | 2022-05-01 | 美商艾弗洛生物科技股份有限公司 | 使用巨型球菌屬物種治療疾病及障礙之組成物及方法 |
JP2023530413A (ja) * | 2020-06-11 | 2023-07-18 | エヴェロ バイオサイエンシズ,インコーポレーテッド | オシロスピラ(Oscillospiraceae)微生物細胞外小胞を使用して疾患及び障害を治療するための組成物及び方法 |
TW202214276A (zh) * | 2020-06-11 | 2022-04-16 | 美商艾弗洛生物科技股份有限公司 | 使用harryflintia acetispora治療疾病和障礙之組成物及方法 |
AU2021291569A1 (en) * | 2020-06-16 | 2022-10-20 | Md Healthcare Inc. | Composition for prevention or treatment of neurological or mental disorders comprising extracellular vesicles derived from lactobacillus paracasei |
CN116056723A (zh) * | 2020-06-22 | 2023-05-02 | 罗塞塔外排体株式会社 | 增强细菌胞外囊泡的癌症治疗效果的方法和组合物 |
KR102469138B1 (ko) * | 2020-07-07 | 2022-11-22 | 주식회사 엘제이바이오 | 파라클로스트리디움 벤조에리티쿰 ks3 균주를 포함하는 가축 사체 분해 촉진용 미생물 제제 |
CN111743922B (zh) * | 2020-07-14 | 2022-03-29 | 华熙生物科技股份有限公司 | 一种提高益生菌在鼻腔中的定植和活性的组合物及在鼻腔护理中的应用 |
EP4185307A1 (en) * | 2020-07-21 | 2023-05-31 | Evelo Biosciences, Inc. | Veillonella parvula strain as an oral therapy for neuroinflammatory diseases |
WO2022029015A2 (en) * | 2020-08-03 | 2022-02-10 | Universiteit Gent | Bacterial compositions with anti-inflammatory activity |
CN111876359A (zh) * | 2020-08-04 | 2020-11-03 | 榆林沙漠王生物科技有限公司 | 一种用于蔬菜残体资源化处理的复配菌剂及其制备方法及应用 |
CN116529355A (zh) * | 2020-08-14 | 2023-08-01 | Ko生物技术有限公司 | 普氏栖粪杆菌菌株及其用途 |
CN112094820B (zh) * | 2020-09-17 | 2021-12-07 | 扬州大学 | 霍氏肠杆菌噬菌体yzu.p.a-5及其应用 |
WO2022061094A1 (en) * | 2020-09-18 | 2022-03-24 | Evelo Biosciences, Inc. | Solid dosage forms of bacteria |
CN112094328A (zh) * | 2020-09-21 | 2020-12-18 | 华南农业大学 | 一种空肠弯曲杆菌外膜囊泡的提取及纯化方法 |
WO2022061123A1 (en) * | 2020-09-21 | 2022-03-24 | Evelo Biosciences, Inc. | Solid dosage forms with improved disintegration profiles |
CN112094778B (zh) * | 2020-09-24 | 2022-06-24 | 千禾味业食品股份有限公司 | 一种魏斯氏菌las1、制备方法及其应用 |
US20240024377A1 (en) * | 2020-10-29 | 2024-01-25 | Evelo Biosciences, Inc. | Compositions comprising spirulina components |
CN114438235A (zh) * | 2020-11-04 | 2022-05-06 | 深圳市南山区疾病预防控制中心 | 一种同时检测嗜低温弓形杆菌及斯氏弓形杆菌的引物探针组件、试剂盒及其应用 |
JP2023554271A (ja) * | 2020-12-08 | 2023-12-27 | エムディー ヘルスケア インコーポレイテッド | スフィンゴモナス細菌由来小胞を含む神経疾患または精神疾患の予防または治療用組成物 |
KR102269962B1 (ko) | 2020-12-11 | 2021-06-28 | 주식회사 바이오뱅크힐링 | 유박테리움 리모숨 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
FR3118060A1 (fr) * | 2020-12-18 | 2022-06-24 | Université de Bourgogne | Utilisation anti-biofilm de vesicules membranaires extracellulaires |
WO2022139531A1 (ko) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | 류코노스톡 시트리움 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물 |
WO2022139530A1 (ko) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | 락토바실러스 사케아이 유래 세포밖 소포체를 유효성분으로 포함하는 자가면역질환의 개선, 예방 또는 치료용 조성물 |
WO2022139532A1 (ko) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | 와이셀라 헬레니카 유래 세포밖 소포체를 유효성분으로 포함하는 지방간 개선, 예방 또는 치료용 조성물 |
WO2022145680A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 엠디헬스케어 | 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 호중구성 폐질환의 예방 또는 치료용 조성물 |
WO2022145902A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | 락토바실러스 사케아이 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
WO2022145900A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | 와이셀라 시바리아 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
JP2024501034A (ja) * | 2020-12-28 | 2024-01-10 | エムディー ヘルスケア インコーポレイテッド | マイクロコッカス・ルテウス由来細胞外小胞を含む神経発達疾患、神経疾患、または精神疾患の予防または治療用組成物 |
KR102651196B1 (ko) * | 2020-12-28 | 2024-03-27 | 주식회사 엠디헬스케어 | 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 안질환 예방 또는 치료용 조성물 |
WO2022145901A1 (ko) * | 2020-12-28 | 2022-07-07 | 주식회사 리스큐어바이오사이언시스 | 락토바실러스 퍼멘텀 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
WO2022154149A1 (ko) * | 2021-01-14 | 2022-07-21 | (주)엑솔런스 | 세포외소포체를 이용한 백신 조성물 |
WO2022164012A1 (ko) * | 2021-02-01 | 2022-08-04 | 주식회사 엠디헬스케어 | 락토바실러스 파라카제이 유래 소포를 포함하는 바이러스 감염 질환 또는 호흡기 질환의 예방, 치료, 또는 개선용 조성물 |
WO2022177412A1 (ko) * | 2021-02-22 | 2022-08-25 | 주식회사 리스큐어바이오사이언시스 | 와이셀라 시바리아 균주 유래 나노소포체를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
US20240148797A1 (en) * | 2021-02-26 | 2024-05-09 | Evelo Biosciences, Inc. | Compositions and methods for reducing cytokine expression |
KR20230175194A (ko) * | 2021-03-12 | 2023-12-29 | 마블바이옴 인코포레이티드 | 마이크로바이옴 조성물, 성분, 또는 대사산물의 눈 장애의 치료를 위한 방법 및 용도 |
WO2022211547A1 (ko) * | 2021-04-02 | 2022-10-06 | 주식회사 엠디헬스케어 | 파라코커스 속 세균 유래 나노소포 및 이의 용도 |
CN113186172A (zh) * | 2021-04-06 | 2021-07-30 | 天津农学院 | 共表达Apoptin与MEL基因的重组腺病毒及构建方法和应用 |
WO2022221183A1 (en) * | 2021-04-12 | 2022-10-20 | Evelo Biosciences, Inc. | Fournierella extracellular vesicle preparations |
CN113025534B (zh) * | 2021-04-26 | 2022-05-27 | 佛山市南海东方澳龙制药有限公司 | 一株具有较强抑菌作用的新种芽孢杆菌x901株及其应用 |
CN115305211A (zh) * | 2021-05-07 | 2022-11-08 | 葡萄王生技股份有限公司 | 益生菌胞外泌体及其用途 |
CN113186134B (zh) * | 2021-05-17 | 2022-11-01 | 中国科学院水生生物研究所 | 一种蓝藻气囊提取方法及其应用 |
CN113122483A (zh) * | 2021-05-31 | 2021-07-16 | 哈尔滨工业大学 | 一种玉米秸秆好氧堆肥的快速产热菌剂及其应用 |
EP4349354A1 (en) * | 2021-06-03 | 2024-04-10 | MD Healthcare Inc. | Extracellular vesicles derived from lactobacillus bacteria, and use thereof |
KR102661178B1 (ko) * | 2021-06-03 | 2024-04-29 | 주식회사 엠디헬스케어 | 락토바실러스 파라카세이 유래 세포외소포를 포함하는 안질환 예방 또는 치료용 조성물 |
JP2024521917A (ja) * | 2021-06-03 | 2024-06-04 | エムディー ヘルスケア インコーポレイテッド | ラクトバチルス・ラムノサス由来小胞及びその用途 |
EP4119151A4 (en) * | 2021-06-03 | 2023-10-25 | MD Healthcare Inc. | COMPOSITION FOR THE PREVENTION OR TREATMENT OF EYE DISEASES COMPRISING EXTRACELLULAR VESICLES FROM LACTOBACILLUS PARACASEI |
WO2022260352A1 (ko) * | 2021-06-07 | 2022-12-15 | 주식회사 엠디헬스케어 | 류코노스톡 세균 유래 소포를 포함하는 염증질환 또는 암 예방 또는 치료용 조성물 |
EP4376880A1 (en) * | 2021-07-28 | 2024-06-05 | The Texas A&M University System | Vaccine compositions comprising brucella strains and methods thereof |
KR102390755B1 (ko) * | 2021-09-06 | 2022-04-28 | 한국식품연구원 | 웨이셀라 파라메센테로이데스 WiKim0137 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
KR102390775B1 (ko) * | 2021-09-06 | 2022-05-04 | 한국식품연구원 | 류코노스톡 슈도메센테로이데스 WiKim0138 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
KR102558084B1 (ko) * | 2021-09-14 | 2023-07-21 | 코스맥스 주식회사 | 두피 마이크로바이옴 콤플렉스 및 그의 모발 또는 두피 상태 개선 용도 |
CN113999789B (zh) * | 2021-09-30 | 2022-11-15 | 沈阳农业大学 | 一株产鲜味肽的嗜盐四联球菌及应用 |
AU2021468875A1 (en) * | 2021-10-11 | 2024-05-30 | Vastu Vihar Biotech Private Limited | An anti-inflammatory composition and a method of obtaining the same |
KR102411241B1 (ko) * | 2021-10-18 | 2022-06-22 | 큐티스바이오 주식회사 | 코리네박테리움 상귀니스의 피부 상태 개선 용도 |
KR102411242B1 (ko) * | 2021-10-18 | 2022-06-22 | 큐티스바이오 주식회사 | 클렙시엘라 아에로제네스의 피부 상태 개선 용도 |
KR20230056619A (ko) * | 2021-10-20 | 2023-04-27 | 주식회사 고바이오랩 | 항암 활성을 갖는 베일로넬라 파르불라 균주를 이용한 암의 완화, 예방 또는 치료용 조성물 |
WO2023075458A1 (ko) * | 2021-10-27 | 2023-05-04 | 주식회사 바이오뱅크힐링 | 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN114085792B (zh) * | 2021-11-17 | 2023-03-24 | 哈尔滨医科大学 | 一种用于防治结肠癌的副干酪乳杆菌及其应用 |
WO2023092141A2 (en) * | 2021-11-22 | 2023-05-25 | Dupont Nutrition Biosciences Aps | Compositions for metabolic health |
CA3238764A1 (en) | 2021-11-23 | 2023-06-01 | Siddharth Patel | A bacteria-derived lipid composition and use thereof |
WO2023114300A1 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Fournierella massiliensis bacteria extracellular vesicle preparations |
WO2023114296A2 (en) * | 2021-12-14 | 2023-06-22 | Evelo Biosciences, Inc. | Extracellular vesicle preparations |
CN114369673B (zh) * | 2022-01-06 | 2023-07-14 | 同济大学 | 结直肠腺瘤生物标志物、试剂盒及生物标志物的筛选方法 |
WO2023140603A1 (ko) * | 2022-01-20 | 2023-07-27 | 한국과학기술연구원 | 로세부리아 속 또는 비피도박테리움 속 유래 세포외소포체를 포함하는, 비알코올성 지방간 질환의 예방, 개선, 또는 치료용 조성물 |
CN114807032B (zh) * | 2022-05-20 | 2023-09-12 | 南京大学 | 地塞米松诱导中性粒细胞产生的细胞外囊泡在制备治疗消炎药物中的应用 |
KR102509869B1 (ko) * | 2022-07-14 | 2023-03-14 | 주식회사 엔테로바이옴 | 아커만시아를 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
KR102620189B1 (ko) * | 2022-08-31 | 2024-01-04 | 주식회사 바이오뱅크힐링 | 블라우티아 브룩킹시 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
KR102620190B1 (ko) * | 2022-08-31 | 2024-01-04 | 주식회사 바이오뱅크힐링 | 아가토박터 렉탈리스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
WO2024049207A1 (ko) * | 2022-08-31 | 2024-03-07 | 주식회사 바이오뱅크힐링 | 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
KR102626400B1 (ko) * | 2022-08-31 | 2024-01-19 | 주식회사 바이오뱅크힐링 | 도레아 론기카테나 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN116509900B (zh) * | 2022-12-01 | 2023-11-10 | 佛山科学技术学院 | 益生菌或其细胞外囊泡在制备防治胃溃疡产品中的应用 |
CN116656583B (zh) * | 2023-01-13 | 2024-06-18 | 南昌大学 | 靶向肿瘤的幽门螺杆菌突变株及抗胃癌外膜囊泡组合物 |
CN116622548B (zh) * | 2023-03-31 | 2024-02-09 | 吉林农业大学 | 一株能够预防和或治疗牙周炎的嵴链球菌及其应用 |
CN117180317B (zh) * | 2023-11-02 | 2024-01-26 | 深圳市第二人民医院(深圳市转化医学研究院) | 詹氏乳杆菌来源纳米囊泡在制备防治卵巢早衰治疗药物中的应用 |
CN117402794B (zh) * | 2023-12-12 | 2024-02-27 | 四川厌氧生物科技有限责任公司 | 一种加氏乳杆菌及其应用 |
CN118006515B (zh) * | 2024-04-08 | 2024-06-18 | 中国农业大学 | 一株乳酸乳球菌及其在制备治疗牛乳腺炎的药物中的应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5322784A (en) | 1991-06-05 | 1994-06-21 | The Board Of Trustees Of The University Of Illinois, Urbana-Champaign, Illinois | Method and materials for introducing DNA into Prevotella ruminicola |
UA73763C2 (en) | 2000-03-01 | 2005-09-15 | Nestle Sa | Carbohydrate composition containing prebiotic for treatment or prevention of measles |
MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
JPWO2004087210A1 (ja) | 2003-03-31 | 2006-06-29 | 麒麟麦酒株式会社 | 抗cd52抗体による調節性t細胞分化誘導・増殖方法およびそのための医薬組成物 |
EP2494865A4 (en) * | 2009-09-01 | 2014-05-14 | Aeon Medix Inc | EXTRACELLULAR VESICLES OBTAINED FROM THE DARMFLORA, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE AND CANDIDATE AND DIAGNOSTIC METHOD THEREFOR |
GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
US8617536B2 (en) | 2009-10-30 | 2013-12-31 | Mayo Foundation For Medical Education And Research | Prevotella histicola preparations and the treatment of autoimmune conditions |
WO2012002760A2 (ko) | 2010-07-01 | 2012-01-05 | 포항공과대학교 산학협력단 | 세균유래 마이크로베시클을 이용한 암치료 및 암진단 방법 |
US9968638B2 (en) * | 2011-03-09 | 2018-05-15 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
WO2014152484A1 (en) * | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Freeze dried fecal microbiota for use in fecal microbial transplantation |
TWI573590B (zh) | 2011-09-20 | 2017-03-11 | 雷希爾生藥有限公司 | 治療自體免疫疾病之組成物及方法 |
WO2013101314A1 (en) | 2011-12-28 | 2013-07-04 | Galectin Therapeutics, Inc. | Composition of novel carbohydrate drug for treatment of human diseases |
WO2014196913A1 (en) | 2013-06-03 | 2014-12-11 | Björck Inger | Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella |
KR101740893B1 (ko) | 2014-05-20 | 2017-06-13 | 주식회사 엠디헬스케어 | Akkermansia muciniphila 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물 |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
WO2016090183A1 (en) | 2014-12-03 | 2016-06-09 | Capricor Therapeutics, Inc. | Processes for producing stable exosome formulations |
US20180050070A1 (en) | 2015-03-12 | 2018-02-22 | The University Of British Columbia | Bacterial compositions and methods of use thereof |
US10722543B2 (en) | 2016-01-28 | 2020-07-28 | Oxyrase, Inc. | Methods for inhibiting tumor growth using anaerobe microorganisms |
JP7369690B2 (ja) | 2017-09-08 | 2023-10-26 | エヴェロ バイオサイエンシズ,インコーポレーテッド | 細菌の細胞外小胞 |
-
2018
- 2018-09-10 JP JP2020513524A patent/JP7369690B2/ja active Active
- 2018-09-10 AR ARP180102564A patent/AR113011A1/es unknown
- 2018-09-10 TW TW107131777A patent/TWI814739B/zh active
- 2018-09-10 US US16/645,019 patent/US11524037B2/en active Active
- 2018-09-10 MA MA050086A patent/MA50086A/fr unknown
- 2018-09-10 WO PCT/US2018/050211 patent/WO2019051380A1/en unknown
- 2018-09-10 MX MX2020002659A patent/MX2020002659A/es unknown
- 2018-09-10 CA CA3075268A patent/CA3075268A1/en active Pending
- 2018-09-10 BR BR112020004264-1A patent/BR112020004264A2/pt unknown
- 2018-09-10 CN CN201880058100.6A patent/CN111148531A/zh active Pending
- 2018-09-10 EP EP18785472.4A patent/EP3678693A1/en active Pending
- 2018-09-10 AU AU2018330322A patent/AU2018330322A1/en not_active Abandoned
- 2018-09-10 KR KR1020207010043A patent/KR20200053531A/ko not_active Application Discontinuation
-
2020
- 2020-04-06 CO CONC2020/0004233A patent/CO2020004233A2/es unknown
-
2022
- 2022-12-02 US US18/074,122 patent/US20230210913A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20200053531A (ko) | 2020-05-18 |
TWI814739B (zh) | 2023-09-11 |
CA3075268A1 (en) | 2019-03-14 |
TW201919673A (zh) | 2019-06-01 |
CN111148531A (zh) | 2020-05-12 |
AR113011A1 (es) | 2020-01-15 |
US11524037B2 (en) | 2022-12-13 |
EP3678693A1 (en) | 2020-07-15 |
MA50086A (fr) | 2020-07-15 |
JP7369690B2 (ja) | 2023-10-26 |
WO2019051380A1 (en) | 2019-03-14 |
US20230210913A1 (en) | 2023-07-06 |
BR112020004264A2 (pt) | 2020-10-06 |
AU2018330322A1 (en) | 2020-03-19 |
US20200254028A1 (en) | 2020-08-13 |
JP2020533290A (ja) | 2020-11-19 |
MX2020002659A (es) | 2020-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2020004233A2 (es) | Vesículas extracelulares bacterianas | |
CO2021012176A2 (es) | Preparaciones de membrana bacteriana | |
CO2022000040A2 (es) | Vesículas extracelulares microbianas procesadas | |
MX2020002660A (es) | Vesiculas extracelulares de prevotella. | |
CY1122227T1 (el) | Ρυθμιση δραστικοτητας συμπληρωματος | |
PH12019500627A1 (en) | Affinity-oligonucleotide conjugates and uses thereof | |
CY1124131T1 (el) | Συζευγματα αντι-ρτκ7 αντισωματος-φαρμακου | |
CO2020007142A2 (es) | Composiciones y métodos para el tratamiento de los trastornos inmunitarios utilizando cepas de bacterias inmunomoduladoras de lactococcus | |
GEP20217239B (en) | Pharmaceutical composition | |
UY36311A (es) | Indazoles sustituidos con bencilo | |
MX2017016405A (es) | Reguladores de nrf2. | |
TWD174683S (zh) | 戒指 | |
UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
CY1124761T1 (el) | Ρυθμιστες της δραστικοτητας του συμπληρωματος | |
CL2018000947S1 (es) | Automóvil | |
CL2019003398A1 (es) | Inhibidores pirazólicos de magl. | |
UY34541A (es) | ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?. | |
MX2023006706A (es) | Administracion transdermica de agentes grandes en composiciones de emulsion mediante acondicionamiento de la piel con microagujas y sus usos. | |
TR201909271T4 (tr) | Testosteron formülasyonları. | |
TWD182433S (zh) | 修枝剪刀(二) | |
MY193650A (en) | Extracellular matrix compositions | |
GEP20217240B (en) | Pharmaceutical composition | |
CL2020000902A1 (es) | Conexión flexible antisísmica | |
MY167350A (en) | Fat-and-oil composition and chocolate | |
CL2018000791S1 (es) | Automóvil |